Andrea B Apolo1, Vanessa Hoffman2, Matthew G Kaag3, David M Latini4, Cheryl T Lee5, Jonathan E Rosenberg6, Margaret Knowles7, Dan Theodorescu8, Bogdan A Czerniak9, Jason A Efstathiou10, Matthew L Albert11, Srikala S Sridhar12, Vitaly Margulis13, Surena F Matin14, Matthew D Galsky15, Donna Hansel16, Ashish M Kamat14, Thomas W Flaig8, Angela B Smith17, Edward Messing18, Diane Zipursky Quale2, Yair Lotan19. 1. Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD. 2. Bladder Cancer Advocacy Network, Bethesda, MD. 3. Department of Urology, Penn State Hershey Medical Center, Hershey, PA. 4. Department of Urology, Baylor College of Medicine, Houston, TX. 5. Department of Urology, University of Michigan Health System, Ann Arbor, MI. 6. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. 7. Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. 8. University of Colorado Cancer Center, Denver, CO. 9. Department of Pathology, MD Anderson Cancer Center, Houston, TX. 10. Harvard Medical School, Massachusetts General Hospital, Boston, MA. 11. Department of Immunology, Institut Pasteur, Paris, France. 12. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. 13. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. 14. Department of Urology, MD Anderson Cancer Center, Houston, TX. 15. Department of Medical Oncology, Mount Sinai Hospital, New York, NY. 16. Department of Pathology, University of California, La Jolla, San Diego, CA. 17. Department of Urology, University of North Carolina, Chapel Hill, NC. 18. Department of Urology, University of Rochester Medical Center, Rochester, NY. 19. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: yair.lotan@utsouthwestern.edu.
Abstract
OBJECTIVES: The 8th Annual Bladder Cancer Think Tank (BCAN-TT) brought together a multidisciplinary group of clinicians, researchers, and patient advocates in an effort to advance bladder cancer research. METHODS AND MATERIALS: With the theme of "Collaborating to Move Research Forward," the meeting included three panel presentations and seven small working groups. RESULTS: The panel presentations and interactive discussions focused on three main areas: gender disparities, sexual dysfunction, and targeting novel pathways in bladder cancer. Small working groups also met to identify projects for the upcoming year, including: (1) improving enrollment and quality of clinical trials; (2) collecting data from multiple institutions for future research; (3) evaluating patterns of care for non-muscle-invasive bladder cancer; (4) improving delivery of care for muscle-invasive disease; (5) improving quality of life for survivors; (6) addressing upper tract disease; and (7) examining the impact of health policy changes on research and treatment of bladder cancer. CONCLUSIONS: The goal of the BCAN-TT is to advance the care of patients with bladder cancer and to promote collaborative research throughout the year. The meeting provided ample opportunities for collaboration among clinicians from multiple disciplines, patients and patient advocates, and industry representatives.
OBJECTIVES: The 8th Annual Bladder Cancer Think Tank (BCAN-TT) brought together a multidisciplinary group of clinicians, researchers, and patient advocates in an effort to advance bladder cancer research. METHODS AND MATERIALS: With the theme of "Collaborating to Move Research Forward," the meeting included three panel presentations and seven small working groups. RESULTS: The panel presentations and interactive discussions focused on three main areas: gender disparities, sexual dysfunction, and targeting novel pathways in bladder cancer. Small working groups also met to identify projects for the upcoming year, including: (1) improving enrollment and quality of clinical trials; (2) collecting data from multiple institutions for future research; (3) evaluating patterns of care for non-muscle-invasive bladder cancer; (4) improving delivery of care for muscle-invasive disease; (5) improving quality of life for survivors; (6) addressing upper tract disease; and (7) examining the impact of health policy changes on research and treatment of bladder cancer. CONCLUSIONS: The goal of the BCAN-TT is to advance the care of patients with bladder cancer and to promote collaborative research throughout the year. The meeting provided ample opportunities for collaboration among clinicians from multiple disciplines, patients and patient advocates, and industry representatives.
Authors: Helena Thulin; Ulrika Kreicbergs; Erik Onelöv; Christer Ahlstrand; Malcolm Carringer; Sten Holmäng; Börje Ljungberg; Per-Uno Malmström; David Robinsson; Hans Wijkström; N Peter Wiklund; Gunnar Steineck; Lars Henningsohn Journal: BJU Int Date: 2010-11-02 Impact factor: 5.588
Authors: S Imaoka; Y Yoneda; T Sugimoto; S Ikemoto; T Hiroi; K Yamamoto; T Nakatani; Y Funae Journal: Cancer Lett Date: 2001-05-26 Impact factor: 8.679
Authors: Jason A Efstathiou; Daphna Y Spiegel; William U Shipley; Niall M Heney; Donald S Kaufman; Andrzej Niemierko; John J Coen; Rafi Y Skowronski; Jonathan J Paly; Francis J McGovern; Anthony L Zietman Journal: Eur Urol Date: 2011-11-12 Impact factor: 20.096
Authors: P Hartge; E B Harvey; W M Linehan; D T Silverman; J W Sullivan; R N Hoover; J F Fraumeni Journal: J Natl Cancer Inst Date: 1990-10-17 Impact factor: 13.506
Authors: Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt Journal: Eur Urol Date: 2011-03-22 Impact factor: 20.096
Authors: Ananya Choudhury; Louisa D Nelson; Mark T W Teo; Sameer Chilka; Selina Bhattarai; Colin F Johnston; Faye Elliott; Johanna Lowery; Claire F Taylor; Michael Churchman; Johanne Bentley; Margaret A Knowles; Patricia Harnden; Robert G Bristow; D Timothy Bishop; Anne E Kiltie Journal: Cancer Res Date: 2010-09-15 Impact factor: 12.701
Authors: Sangkyou Lee; Joon Jeong; Tadeusz Majewski; Steven E Scherer; Mi-Sook Kim; Tomasz Tuziak; Kuang S Tang; Keith Baggerly; Herbert Barton Grossman; Jain-Hua Zhou; Lanlan Shen; Jolanta Bondaruk; Saira S Ahmed; Susmita Samanta; Philippe Spiess; Xifeng Wu; Slawomir Filipek; David McConkey; Menashe Bar-Eli; Jean-Pierre Issa; William F Benedict; Bogdan Czerniak Journal: Proc Natl Acad Sci U S A Date: 2007-08-16 Impact factor: 11.205
Authors: Tim Lautenschlaeger; Asha George; Alexander C Klimowicz; Jason A Efstathiou; Chin-Lee Wu; Howard Sandler; William U Shipley; William J Tester; Michael P Hagan; Anthony M Magliocco; Arnab Chakravarti Journal: Oncologist Date: 2013-05-31
Authors: Elizabeth A Guancial; Breton Roussel; Derek P Bergsma; Kevin C Bylund; Deepak Sahasrabudhe; Edward Messing; Supriya G Mohile; Chunkit Fung Journal: Clin Interv Aging Date: 2015-06-10 Impact factor: 4.458